15:53 Dec 05

Alpa Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
81.31
-1.61 (-1.94%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Alpa Laboratories Ltd. Financials

Alpa Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
81.31
-1.61 (-1.94%)
15:53 Dec 05
Quality
image/svg+xml

48/100
Medium Financial Strength

Valuation
image/svg+xml

52/100
Affordable Valuation

Technical

36/100
Technically Neutral

Strength

9

Weakness

1

Opportunity

0

Threats

0

11.37 %

ROE %

8.76 %

ROA %

8.87

EPS

81.48

BVPS

17.34 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
112.27 92.96 108.74 112.45 111.44
Operating Expenses +
101.6 84.88 100.64 107.7 112.31
Raw Material
69.24 53.67 68.68 71.65 73.47
Increase Decrease in Cost
0.53 1.27 -0.64 -1.45 -0.43
Other Manufacturing Expense
6.31 6.55 6.57 5.85 0
Employee Cost
11.93 12.17 13.29 14.39 14.74
Miscellaneous Expenses
25.23 13.66 24.34 19.12 24.53
Operating Profit
10.67 8.08 8.1 4.75 -0.87
Other Income
10.78 9.37 14.89 23.35 26.28
Depreciation
1.66 1.33 1.95 2.2 2.35
Interest
0.22 0.22 0.36 0.23 0.19
Profit before tax and exceptio..
19.56 15.89 20.68 25.67 22.87
Exceptional Items
0 0 0 0 0
PBT
19.56 15.89 20.68 25.67 22.87
Provision for Taxation
5.47 3.31 3.91 6.16 4.2
Net Profit
14.09 12.58 16.78 19.5 18.66
NET Profit after MI
14.09 12.58 16.78 19.5 18.66
EPS
6.7 5.88 8.01 9.34 8.92
Operating Profit Margin (%)
9.5 8.69 7.45 4.22 -0.78
Net Profit Margin (%)
12.55 13.53 15.43 17.34 16.74

Alpa Laboratories Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 57.30 57.30 57.30 57.30 57.30 57.30
FII 0.40 0.40 0.40 0.40 0.70 0.40
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 42.30 42.30 42.30 42.30 42.00 42.30
Shareholder Shares Holding %
Download Our App On: